• Product NameAtovaquone
• Brief DescriptionInhibitors
• Purification99.85%
• Biological ActivityAtovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia.
• Target NameDehydrogenase inhibitor; Others
• CAS No. 95233-18-4
• Calculated MW 366.84
• Formulation C22H19ClO3
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:OC1=C(C2CCC(CC2)C2=CC=C(Cl)C=C2)C(=O)C(=O)C2=CC=CC=C12
  Pathways:Metabolism; Others
  Receptor:DHODH; Cytochrome b
  Boling pt:542.2C
  Melting pt:216-219C
  Solubility:DMSO: 5 mg/mL (13.62 mM)
  Appearance:Yellow Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Winter RW, et al. Exp Parasitol. 2008 Apr; 118(4):487-97.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting